121 related articles for article (PubMed ID: 38184433)
1. Characteristics and Clinical Outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
[TBL] [Abstract][Full Text] [Related]
2. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
[TBL] [Abstract][Full Text] [Related]
3. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
Sen S; Kadamba P; Al-AbdulAaly M; Mammen KE; Ahmed S
Pediatr Surg Int; 1998 Jan; 13(1):42-4. PubMed ID: 9391203
[TBL] [Abstract][Full Text] [Related]
4. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
Stefanowicz J; Sierota D; Balcerska A; Stoba C
Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
[TBL] [Abstract][Full Text] [Related]
5. MANAGEMENT AND OUTCOME OF PATIENTS WITH WILMS' TUMOUR (NEPHROBLASTOMA) AT THE MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.
Tenge CN; Were PA; Aluoch LH; Wekesa JW; Patel K; Kuremu RT
East Afr Med J; 2012 Apr; 89(4):121-7. PubMed ID: 26856036
[TBL] [Abstract][Full Text] [Related]
6. Childhood Wilms' tumour: prognostic factors in North Central Nigeria.
Uba AF; Chirdan LB
West Afr J Med; 2007; 26(3):222-5. PubMed ID: 18399339
[TBL] [Abstract][Full Text] [Related]
7. Predictors of treatment outcome of Wilms Tumour in low-income country; single centre experience from Pakistan.
Ghafoor T; Bashir F; Ahmed S; Khalil S; Farah T
J Pediatr Urol; 2020 Jun; 16(3):375.e1-375.e7. PubMed ID: 32224063
[TBL] [Abstract][Full Text] [Related]
8. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
[TBL] [Abstract][Full Text] [Related]
9. A 5-year multidisciplinary care outcomes in children with wilms' tumour managed at a tertiary centre: A retrospective observational study.
Alakaloko FM; Akinsete AM; Seyi-Olajide JO; Joseph AO; Elebute OO; Ladipo-Ajayi OA; Odubanjo MO; Olowoyeye OA; Ademuyiwa AO; Temiye EO; Akinsulie AA; Bode CO
Afr J Paediatr Surg; 2022; 19(2):83-88. PubMed ID: 35017377
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Wilms' tumour. Current recommendations.
Mehta MP; Bastin KT; Wiersma SR
Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
[TBL] [Abstract][Full Text] [Related]
11. Multimodal therapy for adult Wilms' tumour: an experience from one centre.
Li JJ; Huang HH; Shen J; Jiang JY; Pan F; Yu ST; Kang Y; Zhao XX; Yan XC; Liang HJ
Clin Transl Oncol; 2011 Sep; 13(9):672-6. PubMed ID: 21865139
[TBL] [Abstract][Full Text] [Related]
12. Management and outcome of pediatric metastatic Wilms' tumor at the National Cancer Institute, Egypt.
Elayadi M; Magdy S; Khalil E; Zekri W
J Egypt Natl Canc Inst; 2020 Apr; 32(1):19. PubMed ID: 32372204
[TBL] [Abstract][Full Text] [Related]
13. Challenges and outcome of Wilms' tumour management in a resource-constrained setting.
Wilde JC; Lameris W; van Hasselt EH; Molyneux EM; Heij HA; Borgstein EG
Afr J Paediatr Surg; 2010; 7(3):159-62. PubMed ID: 20859020
[TBL] [Abstract][Full Text] [Related]
14. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
15. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9.
Boccon-Gibod L; Rey A; Sandstedt B; Delemarre J; Harms D; Vujanic G; De Kraker J; Weirich A; Tournade MF
Med Pediatr Oncol; 2000 Mar; 34(3):183-90. PubMed ID: 10696124
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor: a 25-year review of the role of preoperative chemotherapy.
Capra ML; Walker DA; Mohammed WM; Kapila L; Barbor PR; Sokal M; Robson K; Hewitt M; Stewart R
J Pediatr Surg; 1999 Apr; 34(4):579-82. PubMed ID: 10235327
[TBL] [Abstract][Full Text] [Related]
17. Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms' tumour: findings from the 1991-2001 United Kingdom Children's Cancer Study Group UKW3 Trial.
Powis M; Messahel B; Hobson R; Gornall P; Walker J; Pritchard-Jones K
J Pediatr Surg; 2013 Nov; 48(11):2181-6. PubMed ID: 24210183
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor: the experience of the pediatric unit of Kasr El-Aini center of radiation oncology and nuclear medicine (NEMROCK).
Abd El-Aal HH; Habib EE; Mishrif MM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):308-14. PubMed ID: 17102824
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of advanced Wilms' tumor].
Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
[TBL] [Abstract][Full Text] [Related]
20. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
